(NASDAQ:PODC), LOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, today announced record financial results for the second quarter (“Q2 Fiscal 2026”) and first half (“1H Fiscal 2026”) of its fiscal year ending March 31, 2026. Financial Highlights: Q2 Fiscal 2026 Revenue: $15.2 Million, up 22% […]

(Other OTC:OTLC),(OTC US:OTLC), Breakthrough Review Defines the Next Frontier in Precision Nanomedicine Agoura Hills, CA, and San Diego, CA, Nov. 11, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics Inc. (OTLC) and JV partner Sapu Bioscience today announced the publication of their landmark review article, “Sub-15 nm Nanoparticles for Drug Delivery: Emerging Frontiers and Therapeutic Potential,” in

(NASDAQ:UFG), SINGAPORE, Nov. 11, 2025 (GLOBE NEWSWIRE) — Uni-Fuels Holdings Limited (NASDAQ: UFG), (“Uni-Fuels” or the “Company”), a global provider of marine fuel solutions headquartered in Singapore, today announced the opening of its new office in Limassol, Cyprus. This strategic foray underscores the Company's commitment to expanding its international footprint and connecting with customers across

(NasdaqGM:CSLR),(NasdaqGM:SPWR),(NASDAQ:SPWRW), OREM, Utah, Nov. 11, 2025 (GLOBE NEWSWIRE) — SunPower (herein “SunPower,” the “Company” or Nasdaq: “SPWR”) – a solar technology, services, and installation company – today announced that it has agreed to acquire Ambia Solar (“Ambia”), based in Lindon, Utah, just 1.7 miles from SunPower's HQ. Ambia is the No. 19 U.S. solar company

(TSX:CNT), THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Nov. 11, 2025 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company“) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the second fiscal quarter ended September

HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) — March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to MB-105, the Company's first-in-class autologous CD5-targeted CAR-T cell therapy, in development for relapsed/refractory CD5-positive

Citrin Cooperman Advisors LLC, the premier professional services provider for private, middle market businesses and high net-worth individuals, today announced the joining of Partners and employees from KBFM, a prominent Nashville-based business management and tax firm. The transaction establishes Citrin Cooperman's first physical office in Music City, pushing its headcount above 20 and reinforcing its

(NASDAQ:RDVT), BOCA RATON, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) — Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the Raymond James TMT and Consumer Conference being held December 8-10, 2025 in New York. Derek Dubner, Chief Executive Officer, and Dan MacLachlan, Chief Financial Officer,

(NASDAQ:DARE), SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Dare Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced it will host a live webinar on Monday, November 17, 2025, on the DARE to PLAY(TM) difference with leading

Clearway Health, a specialty pharmacy services company partnering with hospitals and health systems, announces the appointment of its first-ever chief executive officer dedicated to Clearway Health's strategic growth. https://mma.prnewswire.com/media/2818927/Clearway_Health_Brandon_Newman.jpg Brandon Newman, PharmD, MMHC, CSP, joins Clearway Health aschiefexecutiveofficer. Newmanwill drive overall strategy, growth, innovation, and external partnershipsfor Clearway Health.Newman'sdeepexpertisein specialty pharmacy,hospitals,and health systems aligns well